CELON PHARMA S.A. ZY-,10/ PLCLNPH00015 /
| 2024-11-11 8:08:29 AM | Chg. -0.030 | Volume | Bid11:54:12 AM | Ask11:54:12 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 6.540EUR | -0.46% | 0 Turnover: 0.000 |
5.880Bid Size: 250 | 6.510Ask Size: 250 | 318.56 mill.EUR | - | - |
Assets
|
2020 IFRS in th. PLN |
2021 IFRS in th. PLN |
2022 IFRS in th. PLN |
2023 IFRS in th. PLN |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 314,587 | 303,665 | 306,793 | 298,940 | |||||
| Intangible Assets | 41,097 | 29,171 | 21,827 | 14,974 | |||||
| Long-Term Investments | 12,872 | 37,903 | 13,027 | 11,259 | |||||
| Fixed Assets | 412,646 | 428,437 | 405,182 | 379,559 | |||||
| Inventories | 29,760 | 23,376 | 38,385 | 26,406 | |||||
| Accounts Receivable | 32,528 | 24,674 | 27,111 | 32,789 | |||||
| Cash and Cash Equivalents | 43,978 | 147,796 | 82,902 | 32,359 | |||||
| Current Assets | 119,242 | 278,701 | 237,581 | 189,749 | |||||
| Total Assets | 531,888 | 707,138 | 642,763 | 569,308 | |||||
Liabilities
|
2020 IFRS in th. PLN |
2021 IFRS in th. PLN |
2022 IFRS in th. PLN |
2023 IFRS in th. PLN |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 20,480 | 12,681 | 18,306 | 10,705 | |||||
| Long-term debt | - | - | - | - | |||||
| Liabilities to Banks | - | - | - | - | |||||
| Provisions | 0.0000 | 1,446 | - | 3,011 | |||||
| Liabilities | 187,356 | 153,136 | 163,117 | 123,752 | |||||
| Share Capital | - | - | - | - | |||||
| Total Equity | 344,532 | 554,002 | 479,646 | 445,556 | |||||
| Minority Interests | - | - | - | - | |||||
| Total liabilities equity | 531,888 | 707,138 | 642,763 | 569,308 | |||||
Income Statement
|
2020 IFRS in th. PLN |
2021 IFRS in th. PLN |
2022 IFRS in th. PLN |
2023 IFRS in th. PLN |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Revenues | 159,992 | 199,109 | 194,592 | 216,566 | |||||
| Depreciation (total) | 34,540 | 41,342 | 44,095 | 50,016 | |||||
| Operating Result | -3,673 | -10,453 | -37,336 | -27,242 | |||||
| Interest Income | -1,914 | -4,634 | 890 | 7,274 | |||||
| Income Before Taxes | - | - | - | - | |||||
| Income Taxes | -4,671 | -3,480 | 2,831 | 8,156 | |||||
| Minority Interests Profit | - | - | - | - | |||||
| Net Income | -917 | -11,607 | -39,277 | -28,124 | |||||
Per Share
Cash Flow
|
2020 IFRS in th. PLN |
2021 IFRS in th. PLN |
2022 IFRS in th. PLN |
2023 IFRS in th. PLN |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 71,739 | 43,952 | -4,701 | -8,314 | |||||
| Cash Flow from Investing Activities | -53,268 | -121,048 | -31,472 | -21,640 | |||||
| Cash Flow from Financing | 4,251 | 180,914 | -28,721 | -20,589 | |||||
| Decrease / Increase in Cash | - | - | - | - | |||||
| Employees | 467 | 488 | 523 | 515 | |||||
